Is CytomX Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 07:57 PM IST
share
Share Via
As of July 24, 2025, CytomX Therapeutics, Inc. shows a mildly bullish trend, supported by daily moving averages, despite mixed signals from weekly MACD and Bollinger Bands, while year-to-date performance is strong at 98.06%, though it has underperformed over the past 5 and 10 years.
As of 24 July 2025, the technical trend for CytomX Therapeutics, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by daily moving averages indicating mild bullishness, while the weekly MACD and Bollinger Bands show mildly bearish signals. The monthly MACD is mildly bullish, but the RSI indicates a bearish trend. The stock has performed well year-to-date with a return of 98.06% compared to the S&P 500's 12.22%, but it has underperformed over longer periods, particularly in the 5-year and 10-year comparisons.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
CytomX Therapeutics Hits New 52-Week High of $4.62, Up 157%
Nov 07 2025 04:09 PM IST
share
Share Via
CytomX Therapeutics Hits New 52-Week High at $4.16
Nov 04 2025 05:59 PM IST
share
Share Via
CytomX Therapeutics Hits New 52-Week High at $3.28
Oct 01 2025 04:42 PM IST
share
Share Via